<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00488579</url>
  </required_header>
  <id_info>
    <org_study_id>PROFEG</org_study_id>
    <nct_id>NCT00488579</nct_id>
  </id_info>
  <brief_title>Routine Iron Prophylaxis During Pregnancy</brief_title>
  <acronym>PROFEG</acronym>
  <official_title>Routine Iron Prophylaxis During Pregnancy - Effects on Maternal and Child Health in Maputo City and Province (Mozambique)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Istitute For Health and Welfare, Finland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academy of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Istitute For Health and Welfare, Finland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of two policies of iron administration during pregnancy in regard to health and
      program feasibility in an area with endemic malaria and high prevalence of HIV infection. The
      policies are: 1) routine iron prophylaxis, 2) screening and therapy with iron.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the study:

      Comparison of two policies of iron administration during pregnancy in regard to health of the
      mother and infant and program feasibility. The two groups compared are:

        1. Routine iron prophylaxis

        2. Screening of anaemia and therapy with iron

      Hypothesis: group 2 will have better health outcomes.

      Study groups:

      Routine group: 60 mg per day of ferrous sulphate (combination with folic acid) daily.

      Screening and therapy: Hb measurement on each visit, Hb &gt;9g/dl Þ only folic acid, Hb &lt;9g/dl Þ
      60/120 mg of ferrous sulphate daily(+ folic acid)

      Methods:

      A pragmatic randomised controlled trial with non-blind design. Total intended sample size was
      4000 women. Study site: Mozambique, Maputo City. Women are randomised individually and
      allocated into the two groups; 1) Routine iron prophylaxis, 2) Screening and therapy for
      anemia.

      The recruitment of pregnant women was done in two health centres, one in Maputo city and one
      in Maputo Province. The women are followed in prenatal visits and until delivery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preterm delivery</measure>
    <time_frame>Until birth</time_frame>
    <description>Birth &lt;37 gestational weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Low birth weight</measure>
    <time_frame>At birth</time_frame>
    <description>weight &lt;2500g</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>perinatal mortality, complications during pregnancy and birth</measure>
    <time_frame>pregnancy and neonatal period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4326</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>routine iron prophylaxis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>giving 60 mg ferrous sulphate daily (+folic acid)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>screening and therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>doing Hb measurement on each visit, Hb&gt;9g/dl giving only folic acid, Hb&lt;9g/dl giving 60-120 mg of ferrous sulphate daily (+folic acid)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Two policies of iron prophylaxis</intervention_name>
    <description>60mg ferrous sulphate daily (+folic acid); Screening and therapy: Hb measurement on each visit, Hb&gt;9g/dl only folic acid, Hb&lt;9g/dl 60-120 of ferrous sulphate daily (+folic acid).</description>
    <arm_group_label>routine iron prophylaxis</arm_group_label>
    <arm_group_label>screening and therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women at their first prenatal visit

        Exclusion Criteria:

          -  Women under 18 years, high obstetric risk pregnancies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elina Hemminki, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>THL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Baltazar Chilundo</last_name>
    <role>Study Director</role>
    <affiliation>Universidade Eduardo Mondlane</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidade Eduardo Mondlande, Faculty of Medicine, Department of Community Health</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mozambique</country>
  </location_countries>
  <link>
    <url>http://www.thl.fi/en_US/web/en/project?id=28551</url>
    <description>Medical technology in maternity services</description>
  </link>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2007</study_first_submitted>
  <study_first_submitted_qc>June 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2007</study_first_posted>
  <last_update_submitted>November 29, 2017</last_update_submitted>
  <last_update_submitted_qc>November 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Istitute For Health and Welfare, Finland</investigator_affiliation>
    <investigator_full_name>Elina Hemminki</investigator_full_name>
    <investigator_title>MD, Research Professor, THL</investigator_title>
  </responsible_party>
  <keyword>iron prophylaxis</keyword>
  <keyword>pregnancy</keyword>
  <keyword>birth weight</keyword>
  <keyword>prematurity</keyword>
  <keyword>perinatal mortality</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

